Rates of long-term treatment discontinuation were low among patients with ankylosing spondylitis receiving first-line anti-TNF therapy for at least 2 years.
The global ankylosing spondylitis treatment market is witnessing significant growth, with projections indicating a market value of USD 8.06 billion in 2022 and an expected increase to USD 5.1409 ...
A Center Township man and his wife have filed a lawsuit claiming a yearslong delay in diagnosing his kidney disease led to him developing irreversible end state renal disease. Chad and Michelle Kuzar ...
Discover the causes and remedies for morning stiffness in arthritis. Learn how inflammation and limited joint movement contribute to this common condition and explore effective strategies to manage ...
Johnson & Johnson’s portfolio now includes treatment options for patients with rheumatoid arthritis, axial spondylarthritis, and polyarticular juvenile idiopathic arthritis.High Wycombe, UK, 17 ...
US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...